OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis
Shanshan Wu, Yanhai Wang, Jiaojiao Zhang, et al.
African Health Sciences (2020) Vol. 20, Iss. 2, pp. 871-884
Open Access | Times Cited: 7
Shanshan Wu, Yanhai Wang, Jiaojiao Zhang, et al.
African Health Sciences (2020) Vol. 20, Iss. 2, pp. 871-884
Open Access | Times Cited: 7
Showing 7 citing articles:
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis
Kang Li, Yanqiu Yu, Yuan Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Kang Li, Yanqiu Yu, Yuan Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway
Hong Chen, Liju Tao, Juhua Liang, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 6
Hong Chen, Liju Tao, Juhua Liang, et al.
Molecular Medicine Reports (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 6
Can we predict if patients with SLE will require more than one cycle of rituximab?
Raquel Fernández González, Rym Abida, Eugeniu Gisca, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1892-1899
Open Access | Times Cited: 4
Raquel Fernández González, Rym Abida, Eugeniu Gisca, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 5, pp. 1892-1899
Open Access | Times Cited: 4
In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care
Tsvetelina Velikova, Dimitrina Miteva, Maria Kokudeva, et al.
Rheumato (2024) Vol. 4, Iss. 3, pp. 120-136
Open Access
Tsvetelina Velikova, Dimitrina Miteva, Maria Kokudeva, et al.
Rheumato (2024) Vol. 4, Iss. 3, pp. 120-136
Open Access
Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus
Daria A. Gerasimova, Vladimir Gontarenko, Е. В. Герасимова, et al.
Modern Rheumatology Journal (2024) Vol. 18, Iss. 5, pp. 31-37
Open Access
Daria A. Gerasimova, Vladimir Gontarenko, Е. В. Герасимова, et al.
Modern Rheumatology Journal (2024) Vol. 18, Iss. 5, pp. 31-37
Open Access
Inflammatory mediators and immune function in different stages of systemic lupus erythematosus
Lixiu Zhu, Sujuan Zhou, Ye Lin, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 2, pp. 150-156
Open Access | Times Cited: 1
Lixiu Zhu, Sujuan Zhou, Ye Lin, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 2, pp. 150-156
Open Access | Times Cited: 1
